Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment

222Citations
Citations of this article
180Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A role for cellular inhibitors of apoptosis (IAPs [cIAPs]) in preventing CD95 death has been suspected but not previously explained mechanistically. In this study, we find that the loss of cIAPs leads to a dramatic sensitization to CD95 ligand (CD95L) killing. Surprisingly, this form of cell death can only be blocked by a combination of RIP1 (receptor-interacting protein 1) kinase and caspase inhibitors. Consistently, we detect a large increase in RIP1 levels in the CD95 death-inducing signaling complex (DISC) and in a secondary cytoplasmic complex (complex II) in the presence of IAP antagonists and loss of RIP1-protected cells from CD95L/IAP antagonist - induced death. Cells resistant to CD95L/IAP antagonist treatment could be sensitized by short hairpin RNA - mediated knockdown of cellular FLICE-inhibitory protein (cFLIP). However, only cFLIPL and not cFLIPS interfered with RIP1 recruitment to the DISC and complex II and protected cells from death. These results demonstrate a fundamental role for RIP1 in CD95 signaling and provide support for a physiological role of caspase-independent death receptor - mediated cell death. © 2009 Geserick et al.

Cite

CITATION STYLE

APA

Geserick, P., Hupe, M., Moulin, M., Wong, W. W. L., Feoktistova, M., Kellert, B., … Leverkus, M. (2009). Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment. Journal of Cell Biology, 187(7), 1037–1054. https://doi.org/10.1083/jcb.200904158

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free